What Nuvation Bio AI does
Nuvation Bio uses AI to design more efficient clinical trials, identify patient cohorts, and predict trial outcomes. The platform reduces time to market for novel therapeutics by optimizing trial design.
Nuvation Bio AI is a healthcare tool on Falcoscan. AI clinical trial design and patient matching platform. Falcoscan rates Nuvation Bio AI with an Opportunity score of 84/100, a Saturation score of 8/100, and a Wrapper-risk score of 13/100. Market signal: hot. Nuvation Bio AI is founded in 2018, currently at Series_a stage. Pricing: Paid. Falcoscan rating 4.5/5.